Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
4.010
+0.010 (0.25%)
At close: Feb 18, 2026, 4:00 PM EST
4.100
+0.090 (2.24%)
After-hours: Feb 18, 2026, 4:10 PM EST
Shattuck Labs Market Cap
Shattuck Labs has a market cap or net worth of $253.75 million as of February 18, 2026. Its market cap has increased by 358.22% in one year.
Market Cap
253.75M
Enterprise Value
170.25M
1-Year Change
358.22%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since the IPO on October 9, 2020, Shattuck Labs's market cap has decreased from $677.31M to $253.75M, a decrease of -62.54%. That is a compound annual growth rate of -16.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 253.12M | 9.59% |
| Dec 31, 2025 | 230.97M | 299.85% |
| Dec 31, 2024 | 57.77M | -82.81% |
| Dec 29, 2023 | 336.08M | 244.71% |
| Dec 30, 2022 | 97.50M | -72.88% |
| Dec 31, 2021 | 359.52M | -83.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 266.42M |
| Enlivex Therapeutics | 265.87M |
| Climb Bio | 262.59M |
| X4 Pharmaceuticals | 261.44M |
| Opus Genetics | 258.62M |
| AC Immune | 257.77M |
| Larimar Therapeutics | 252.92M |
| Palisade Bio | 251.82M |